Triglav Skladi’s Pfizer PFE Stock Holding History

Triglav Skladi’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.03M	Sell	316,700 -16,300	-5%	-$434K	0.46%	37
2026 Q2	$8.02M	Buy	333,000 +16,300	+5%	+$426K	0.42%	46
2026 Q1	$8.89M	Sell	316,700 -99,092	-24%	-$2.64M	0.62%	31
2025 Q4	$10.4M	Buy	415,792 +99,092	+31%	+$2.5M	0.65%	35
2025 Q3	$8.07M	Hold	316,700	–	–	0.53%	41
2025 Q2	$7.68M	Hold	316,700	–	–	0.55%	36
2025 Q1	$8.03M	Hold	316,700	–	–	0.67%	37
2024 Q4	$8.4M	Buy	+316,700	New	+$8.59M	0.66%	35

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Triglav Skladi's PFE Position: Q3 2026 in Review

Triglav Skladi reduced its Pfizer (PFE) stake by 4.9% in Q3 2026, selling an estimated $434K and leaving 316,700 shares worth $9.03M. The position accounts for 0.46% of the portfolio, ranked #37.

Triglav Skladi first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.4M in Q4 2025. 1,765 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Triglav Skladi held 316,700 shares of Pfizer worth $9.03M as of Q3 2026.
Triglav Skladi sold 16,300 Pfizer shares in Q3 2026, an estimated $434K.
Pfizer made up 0.46% of Triglav Skladi's portfolio in Q3 2026, its #37 holding.
Triglav Skladi first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
Triglav Skladi's Pfizer position peaked at $10.4M in Q4 2025.
1,765 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.